The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Epilepsy and Cognitive Impairments in Alzheimer Disease
Open accessAbstract
Alzheimer disease (AD) is associated with cognitive decline and increased incidence of seizures. Seizure activity in AD has been widely interpreted as a secondary process resulting from advanced stages of neurodegeneration, perhaps in combination with other age-related factors. However, recent findings in animal models of AD have challenged this notion, raising the possibility that aberrant excitatory neuronal activity represents a primary upstream mechanism that may contribute to cognitive deficits in these models. The following observations suggest that such activity may play a similar role in humans with AD: (1) patients with sporadic AD have an increased incidence of seizures that appears to be independent of disease stage and highest in cases with early onset; (2) seizures are part of the natural history of many pedigrees with autosomal dominant early-onset AD, including those with mutations in presenilin-1, presenilin-2, or the amyloid precursor protein, or with duplications of wild-type amyloid precursor protein; (3) inheritance of the major known genetic risk factor for AD, apolipoprotein E4, is associated with subclinical epileptiform activity in carriers without dementia; and (4) some cases of episodic amnestic wandering and disorientation in AD are associated with epileptiform activity and can be prevented with antiepileptic drugs. Here we review recent experimental data demonstrating that high levels of beta-amyloid in the brain can cause epileptiform activity and cognitive deficits in transgenic mouse models of AD. We conclude that beta-amyloid peptides may contribute to cognitive decline in AD by eliciting similar aberrant neuronal activity in humans and discuss potential clinical and therapeutic implications of this hypothesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Patients with EOFAD have an 87-fold increased incidence of seizures relative to the age-matched population compared to a threefold increase in seizure incidence in LOAD individuals [6].”
From Microglia specific deletion of miR-155 in Alzheimer’s disease mouse models reduces amyloid-β pathology but causes hyperexcitability and seizures (2023) · cites this paper as [6]
Experimental — accuracy not yet measuredIn the citing paper
“Hyperexcitability is present in AD brain [142] and epilepsy was shown to promote plaque pathology [110].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [142]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892
Self-citationPalop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., Yoo, J., Ho, K. O., Yu, G.-Q., Kreitzer, A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.025 · Cited by 1,653
Self-citationAPP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592
Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123
AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss
Hsieh, H., Boehm, J., Sato, C., Iwatsubo, T., Tomita, T., Sisodia, S., & Malinow, R. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.035 · Cited by 1,042
Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
Chapman, P. F., White, G. L., Jones, M. W., Cooper-Blacketer, D., Marshall, V. J., Irizarry, M., Younkin, L., Good, M. A., Bliss, T. V. P., Hyman, B. T., et al. (1999) · Nature Neuroscience · doi:10.1038/6374 · Cited by 946
Mahley, R. W., Weisgraber, K. H., & Huang, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600549103 · Cited by 912
Cited by
Sorted by citations
Items 201–300 of 675
Spoleti, E., Barbera, L. L., Cauzzi, E., Paolis, M. L. D., Saba, L., Marino, R., Sciamanna, G., Lazzaro, V. D., Keller, F., Nobili, A., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02408-9 · Cited by 63
Ping, Y., Hahm, E.-T., Waro, G., Song, Q., Vo-Ba, D.-A., Licursi, A., Bao, H., Ganoe, L., Finch, K., & Tsunoda, S. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005025 · Cited by 61
Goutagny, R., & Krantic, S. M. (2013) · Europe PMC (PubMed Central) · Cited by 61
Lam, P., Newland, J., Faull, R. L. M., & Kwakowsky, A. (2023) · Molecules · doi:10.3390/molecules28031344 · Cited by 59
Alzheimer‘s Disease and Epilepsy: Insight From Animal Models
Scharfman, H. E. (2012) · Future Neurology · doi:10.2217/fnl.12.8 · Cited by 60
A Novel Nicotinic Mechanism Underlies β-Amyloid-Induced Neuronal Hyperexcitation
Liu, Q., Xie, X., Lukas, R. J., John, P. A. S., & Wu, J. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3235-12.2013 · Cited by 64
Malkov, A., Popova, I., Ivanov, A., Jang, S.-S., Yoon, S. Y., Osypov, A., Huang, Y., Zilberter, Y., & Zilberter, M. (2021) · Communications Biology · doi:10.1038/s42003-021-02551-x · Cited by 59
Therapeutic Strategies to Target Calcium Dysregulation in Alzheimer’s Disease
Calvo-Rodríguez, M., Kharitonova, E. K., & Bacskai, B. J. (2020) · Cells · doi:10.3390/cells9112513 · Cited by 60
Babiloni, C., Lopez, S., Percio, C. D., Noce, G., Pascarelli, M. T., Lizio, R., Teipel, S. J., González‐Escamilla, G., Bakardjian, H., George, N., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.01.012 · Cited by 61
Systematic review of coexistent epileptic seizures and Alzheimer's disease: Incidence and prevalence
Xu, Y. H., Lavrencic, L. M., Radford, K. A., Booth, A., Yoshimura, S., Anstey, K. J., Anderson, C. S., & Peters, R. K. (2021) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17101 · Cited by 58
Seizures exacerbate excitatory: inhibitory imbalance in Alzheimer’s disease and 5XFAD mice
Barbour, A. J., Gourmaud, S., Lancaster, E., Li, X., Stewart, D. A., Hoag, K., Irwin, D. J., Talos, D. M., & Jensen, F. E. (2024) · Brain · doi:10.1093/brain/awae126 · Cited by 59
Characterization of Epileptic Spiking Associated With Brain Amyloidosis in APP/PS1 Mice
Gureviciene, I., Govorova, I. A., Ziyatdinova, S., Jin, N., Lipponen, A., Gurevicius, K., & Tanila, H. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01151 · Cited by 58
Lisgaras, C. P., & Scharfman, H. E. (2022) · Epilepsia · doi:10.1111/epi.17462 · Cited by 58
Intracellular calcium signalling in Alzheimer’s disease
Hermes, M., Eichhoff, G., & Garaschuk, O. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00976.x · Cited by 57
Functional magnetic resonance imaging as a dynamic candidate biomarker for Alzheimer's disease
Prvulovic, D., Bokde, A. L. W., Faltraco, F., & Hampel, H. J. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.05.008 · Cited by 57
Incidence and risk of seizures in Alzheimer's disease: A nationwide population-based cohort study
Cheng, C., Liu, C., Ou, S., Yeh, C., Chen, T., Lin, Y., & Wang, S. (2015) · Epilepsy Research · doi:10.1016/j.eplepsyres.2015.05.009 · Cited by 55
A New Player in the “Synaptopathy” of Alzheimer’s Disease – Arc/Arg 3.1
Kerrigan, T. L., & Randall, A. D. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00009 · Cited by 57
Altered intrinsic excitability of hippocampal CA1 pyramidal neurons in aged PDAPP mice
Tamagnini, F., Novelia, J., Kerrigan, T. L., Brown, J. T., Tsaneva-Atanasova, K. T., & Randall, A. D. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00372 · Cited by 59
Amyloid-β(25-35) Modulates the Expression of GirK and KCNQ Channel Genes in the Hippocampus
Mayordomo‐Cava, J., Yajeya, J., Navarro‐López, J. D., & Jiménez‐Díaz, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134385 · Cited by 55
Schilling, L. P., Balthazar, M. L. F., Radanovic, M., Forlenza, O. V., Silagi, M. L., Smid, J., Barbosa, B. J. A. P., Frota, N. A. F., de Souza, L. C., Vale, F. A. C., et al. (2022) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2022-s102pt · Cited by 59
Sánchez‐Rodríguez, I., Djebari, S., Temprano‐Carazo, S., Vega‐Avelaira, D., Jiménez‐Herrera, R., Iborra‐Lázaro, G., Yajeya, J., Jiménez‐Díaz, L., & Navarro‐López, J. D. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14946 · Cited by 54
Song, Z., Insel, P. S., Buckley, S. T., Yohannes, S., Mezher, A. F., Simonson, A., Wilkins, S., Tosun, D., Mueller, S. G., Kramer, J. H., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2092-14.2015 · Cited by 55
Peineau, S., Rabiant, K., Pierrefiche, O., & Potier, B. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.018 · Cited by 56
Video‐triggered EEG‐emotion public databases and current methods: A survey
Hu, W., Huang, G., Li, L., Zhang, L., Zhang, Z., & Liang, Z. (2020) · Brain Science Advances · doi:10.26599/bsa.2020.9050026 · Cited by 54
Lagostena, L., Rosato‐Siri, M. D., D’Onofrio, M., Brandi, R., Arisi, I., Capsoni, S., Franzot, J., Cattaneo, A., & Cherubini, E. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3326-09.2010 · Cited by 51
Selective Degeneration of Entorhinal-CA1 Synapses in Alzheimer's Disease via Activation of DAPK1
Shu, S., Zhu, H., Tang, N., Chen, W., Li, X., Li, H., Pei, L., Liu, D., Mu, Y., Tian, Q., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.2258-16.2016 · Cited by 51
Hernandez, A. R., Hernandez, C. M., Campos, K. T., Truckenbrod, L. M., Sakarya, Y., McQuail, J. A., Carter, C. S., Bizon, J. L., Maurer, A. P., & Burke, S. N. (2017) · The Journals of Gerontology Series A · doi:10.1093/gerona/glx193 · Cited by 52
Li, W., Jia, Y., Liu, Y., Huang, X., Abumaria, N., Zhu, Y., Huang, X., Xiong, W., Ren, C., Liu, X., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4610-12.2013 · Cited by 51
RetractedProctor, D. T., Coulson, E. J., & Dodd, P. R. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.02.002 · Cited by 53
Khan, M. Z. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.02.026 · Cited by 50
Tran, T., Speck, C. L., Pisupati, A., Gallagher, M., & Bakker, A. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.12.002 · Cited by 50
Tau secretion is correlated to an increase of Golgi dynamics
Mohamed, N., Desjardins, A., & Leclerc, N. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178288 · Cited by 55
Zhen, J., Qian, Y., Weng, X., Su, W., Zhang, J., Cai, L., Dong, L., An, H., Su, R., Wang, J., et al. (2017) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.07.002 · Cited by 52
Entorhinal cortical defects in Tg2576 mice are present as early as 2–4 months of age
Duffy, Á., Morales‐Corraliza, J., Bermudez‐Hernandez, K., Schaner, M. J., Magagna‐Poveda, A., Mathews, P. M., & Scharfman, H. E. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.001 · Cited by 52
Damar, U., Gersner, R., Johnstone, J. T., Schachter, S. C., & Rotenberg, A. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.12.006 · Cited by 49
Sánchez‐Rodríguez, I., Temprano‐Carazo, S., López, A. N., Djebari, S., Yajeya, J., Gruart, A., Delgado-Garcia, J. M., Jiménez‐Díaz, L., & Navarro‐López, J. D. (2017) · Scientific Reports · doi:10.1038/s41598-017-15306-8 · Cited by 49
Increased risk of epilepsy in patients registered in the Swedish Dementia Registry
Zelano, J., Brigo, F., & Ptacek, S. G. (2019) · European Journal of Neurology · doi:10.1111/ene.14043 · Cited by 49
The role of mTORC1 activation in seizure-induced exacerbation of Alzheimer's disease
Gourmaud, S., Stewart, D. A., Irwin, D. J., Roberts, N., Barbour, A. J., Eberwine, G., O’Brien, W. T., Vassar, R. J., Talos, D. M., & Jensen, F. E. (2021) · Brain · doi:10.1093/brain/awab268 · Cited by 50
Hyperphosphorylated tau is implicated in acquired epilepsy and neuropsychiatric comorbidities.
Zheng, P., Shultz, S. R., Hovens, C. M., Velakoulis, D., Jones, N. C., & O’Brien, T. J. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8601-9 · Cited by 48
Born to Protect: Leveraging BDNF Against Cognitive Deficit in Alzheimer’s Disease
Caffino, L., Mottarlini, F., & Fumagalli, F. (2020) · CNS Drugs · doi:10.1007/s40263-020-00705-9 · Cited by 48
Giesers, N. K., & Wirths, O. (2020) · ASN Neuro · doi:10.1177/1759091420925356 · Cited by 47
Early Molecular Changes in Alzheimer Disease: Can We Catch the Disease in its Presymptomatic Phase?
Wirz, K. T. S., Keitel, S., Swaab, D. F., Verhaagen, J., & Bossers, K. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130920 · Cited by 47
Greenberg, D. A., & Subaran, R. L. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2010.02734.x · Cited by 48
Brief update on different roles of tau in neurodegeneration
Ittner, A., Ke, Y. D., van Eersel, J., Gladbach, A., Götz, J., & Ittner, L. M. (2011) · IUBMB Life · doi:10.1002/iub.467 · Cited by 49
The Paroxysmal Depolarization Shift: Reconsidering Its Role in Epilepsy, Epileptogenesis and Beyond
Kubista, H., Boehm, S., & Hoťka, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030577 · Cited by 47
Fyn-tau Ablation Modifies PTZ-Induced Seizures and Post-seizure Hallmarks of Early Epileptogenesis
Putra, M. R. E., Puttachary, S., Liu, G., Lee, G. S., & Thippeswamy, T. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.592374 · Cited by 48
Xia, Y., Qadota, H., Wang, Z.-H., Liu, P., Liu, X., Ye, K. X., Matheny, C. J., Berglund, K., Yu, S. P., Drake, D., et al. (2022) · Science Advances · doi:10.1126/sciadv.abj8658 · Cited by 46
Tang, X., Wu, D., Gu, L., Nie, B., Qi, X., Wang, Y., Wu, F., Li, X.-L., Bai, F., Chen, X., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11353 · Cited by 46
β-Amyloid triggers aberrant over-scaling of homeostatic synaptic plasticity
Gilbert, J. P., Shu, S., Yang, X., Lu, Y., Zhu, L., & Man, H. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0398-0 · Cited by 48
George, A. A., Vieira, J. M., Xavier-Jackson, C., Gee, M. T., Cirrito, J. R., Bimonte‐Nelson, H. A., Picciotto, M. R., Lukas, R. J., & Whiteaker, P. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.0876-20.2020 · Cited by 49
Lehmann, L. M., Lo, A., Knox, K. M., & Barker‐Haliski, M. L. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03332-y · Cited by 48
Adenosine Dysfunction and Adenosine Kinase in Epileptogenesis
Boison, D. (2010) · The Open Neuroscience Journal · doi:10.2174/1874082001004010093 · Cited by 46
Kerrigan, T. L., Brown, J. T., & Randall, A. D. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.004 · Cited by 46
Emergence of a seizure phenotype in aged apolipoprotein epsilon 4 targeted replacement mice
Hunter, J. M., Cirrito, J. R., Restivo, J. L., Kinley, R. D., Sullivan, P. M., Holtzman, D. M., Koger, D., Delong, C., Lin, S., Zhao, L., et al. (2012) · Brain Research · doi:10.1016/j.brainres.2012.05.048 · Cited by 45
Wang, X., Zhang, X., Zhou, T.-T., Li, N., Jang, C.-Y., Xiao, Z., Ma, Q., & Li, S. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00094 · Cited by 45
Tok, S., Ahnaou, A., & Drinkenburg, W. H. I. M. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210397 · Cited by 45
Aloi, M. S., Prater, K. E., Sánchez, R. E. A., Beck, A., Pathan, J. L., Davidson, S., Wilson, A., Keene, C. D., de la Iglesia, H., Jayadev, S., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02745-6 · Cited by 43
Lin, J., Li, X., Yuan, F., Lin, L., Cook, C. L., Rao, C. V., & Lei, Z. M. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181d072cf · Cited by 43
Ren, S., Chen, P.-Z., Jiang, H., Mi, Z., Xu, F., Hu, B., Zhang, J., & Zhu, Z.-R. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.07.050 · Cited by 43
Analyzing and Modeling the Dysfunction of Inhibitory Neurons in Alzheimer’s Disease
Perez, C., Žiburkus, J., & Ullah, G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168800 · Cited by 45
Sinha, N., Berg, C. N., Tustison, N. J., Shaw, A., Hill, D., Yassa, M. A., & Gluck, M. A. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.05.023 · Cited by 46
The prevalence and clinical features of epileptic seizures in a memory clinic population
Baker, J., Libretto, T., Henley, W., & Zeman, A. Z. (2019) · Seizure · doi:10.1016/j.seizure.2019.06.016 · Cited by 44
Neuronal Activity and Amyloid Plaque Pathology: An Update
Ovsepian, S. V., & O’Leary, V. B. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150544 · Cited by 42
Arendt, T., Stieler, J., & Holzer, M. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1342-8 · Cited by 46
The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy
Soler, H., Dorca‐Arévalo, J., González, M., Rubio, S. E., Ávila, J., Soriano, E., & Pascual, M. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.09.006 · Cited by 41
Vijayan, M., Alvir, R. V., Alvir, R. V., Bunquin, L. E., Pradeepkiran, J. A., & Reddy, P. H. (2022) · Aging Cell · doi:10.1111/acel.13663 · Cited by 40
Mortality From Alzheimer’s Disease, Parkinson’s Disease, and Dementias in France and Italy
Désesquelles, A., Demuru, E., Salvatore, M. A., Pappagallo, M., Frova, L., Meslé, F., & Egidi, V. (2014) · Journal of Aging and Health · doi:10.1177/0898264313514443 · Cited by 42
Dissecting Alzheimer disease in Down syndrome using mouse models
Choong, X. Y., Tosh, J., Pulford, L. J., & Fisher, E. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00268 · Cited by 41
Schultz, M. K., Gentzel, R. C., Usenovic, M., Gretzula, C. A., Ware, C., Parmentier‐Batteur, S., Schachter, J. B., & Zariwala, H. A. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.07.003 · Cited by 45
Rujeedawa, T., Félez, E. C., Clare, I. C. H., Fortea, J., Strydom, A., Rebillat, A., Coppus, A. M. W., Levin, J., & Zaman, S. H. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194582 · Cited by 43
Early cerebrovascular inflammation in a transgenic mouse model of Alzheimer's disease
Yu, D., Corbett, B. F., Yan, Y., Zhang, G., Reinhart, P. H., Cho, S. J., & Chin, J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.02.023 · Cited by 39
Breuer, L. E. M., Grevers, E., Boon, P., Bernas, A., Bergmans, J. W. M., Besseling, R. M. H., Klooster, D., de Louw, A. J. A., Mestrom, R., Vonck, K. E. J., et al. (2016) · Acta Neurologica Scandinavica · doi:10.1111/ane.12700 · Cited by 39
Metabolic correction by pyruvate halts acquired epilepsy in multiple rodent models
Popova, I. Y., Malkov, A., Ivanov, A., Samokhina, E., Buldakova, S., Gubkina, O., Osypov, A. A., Muhammadiev, R. S., Zilberter, T., Molchanov, M. V., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.07.012 · Cited by 39
Mechanisms Involved in Epileptogenesis in Alzheimer’s Disease and Their Therapeutic Implications
Altuna, M., Olmedo‐Saura, G., Carmona‐Iragui, M., & Fortea, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084307 · Cited by 43
Moreno, H., Burghardt, N. S., Vela‐Duarte, D., Masciotti, J. M., Hua, F., Fenton, A. A., Schwaller, B., & Small, S. A. (2011) · Hippocampus · doi:10.1002/hipo.20957 · Cited by 39
Ramos‐Miguel, A., Sawada, K., Jones, A. A., Thornton, A. E., Barr, A. M., Leurgans, S. E., Schneider, J. A., Bennett, D. A., & Honer, W. G. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1647-9 · Cited by 40
Adenosine Kinase Inhibition Protects against Cranial Radiation-Induced Cognitive Dysfunction
Acharya, M. M., Baulch, J. E., Lusardi, T. A., Allen, B. D., Chmielewski, N. N., Baddour, A. A. D., Limoli, C. L., & Boison, D. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00042 · Cited by 38
Li, G., Hsu, L., Wu, Y., Bozoki, A., Shih, Y. I., & Yap, P. (2025) · Communications Medicine · doi:10.1038/s43856-025-00736-7 · Cited by 46
Chen, Y., Gao, X., Liu, Q., Zeng, L., Zhang, K., Mu, K., Zhang, D., Zou, H., Wu, N., Ou, J., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107843 · Cited by 37
Sirtuin 3 (SIRT3) Pathways in Age-Related Cardiovascular and Neurodegenerative Diseases
Silaghi, C. N., Farcas, M. F., & Craciun, A. M. (2021) · Biomedicines · doi:10.3390/biomedicines9111574 · Cited by 37
Keller, L., Welander, H., Chiang, H., Tjernberg, L. O., Nennesmo, I., Wallin, Å. K., & Graff, C. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.107 · Cited by 40
Animal Models for Alzheimer’s Disease and Frontotemporal Dementia: A Perspective
Götz, J., & Götz, N. N. (2009) · ASN NEURO · doi:10.1042/an20090042 · Cited by 38
Network Excitability Dysfunction in Alzheimer's Disease: Insights from In Vitro and In Vivo Models
Santos, S. F., Pierrot, N., & Octave, J. (2010) · Reviews in the Neurosciences · doi:10.1515/revneuro.2010.21.3.153 · Cited by 37
AED Treatment through Different Ages: As Our Brains Change, Should Our Drug Choices Also?
French, J. A., & Staley, B. A. (2012) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7511-12.4s.22 · Cited by 37
A viral vector expressing hypoxia-inducible factor 1 alpha inhibits hippocampal neuronal apoptosis
Sun, Y., Chai, X.-Q., Kong, W., Liu, L., Yu, W., & Zhang, Z. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.135317 · Cited by 36
Do we know how to diagnose epilepsy early in Alzheimer's disease?
Cretin, B., Philippi, N., Bousiges, O., Bitonto, L. D., Sellal, F., Martin‐Hunyadi, C., & Blanc, F. (2017) · Revue Neurologique · doi:10.1016/j.neurol.2017.03.028 · Cited by 36
Neurotransmitter Pathway Genes in Cognitive Decline During Aging: Evidence for GNG4 and KCNQ2 Genes
Bonham, L. W., Evans, D. S., Liu, Y., Cummings, S. R., Yaffe, K. S., & Yokoyama, J. S. (2018) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317517739384 · Cited by 37
Joseph, S., Knezevic, D., Zomorrodi, R., Blumberger, D. M., Daskalakis, Z. J., Mulsant, B. H., Pollock, B. G., Voineskos, A. N., Wang, W., Rajji, T. K., et al. (2021) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2021.08.008 · Cited by 38
Zheng, X., Lv, Y.-D., Jin, F., Zhang, H., Wu, X., Zhu, J., & Ruan, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.888784 · Cited by 36
Alterations of resting-state Gamma frequency characteristics in aging and Alzheimer’s disease
Güntekin, B., Erdal, F., Bölükbaş, B., Hanoğlu, L., Yener, G., & Duygun, R. (2022) · Cognitive Neurodynamics · doi:10.1007/s11571-022-09873-4 · Cited by 37
Progressive myoclonus epilepsy in Down syndrome patients with dementia
On behalf of the Apulian Study Group on Senile Myoclonic Epilepsy, d’Orsi, G., & Specchio, L. M. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7376-x · Cited by 36
Paesler, K., Xie, K., Hettich, M. M., Siwek, M. E., Ryan, D. P., Schröder, S., Papazoglou, A., Broich, K., Müller, R., Trog, A., et al. (2015) · Neural Plasticity · doi:10.1155/2015/825157 · Cited by 36
“Untangling” Alzheimer's Disease and Epilepsy
Scharfman, H. E. (2012) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7511-12.5.178 · Cited by 36
CRISPRi-based screens in iAssembloids to elucidate neuron-glia interactions
Li, E., Benitez, C., Boggess, S. C., Koontz, M., Rose, I. V. L., Martinez, D., Dräger, N. M., Teter, O. M., Samelson, A. J., Pierce, N., et al. (2025) · Neuron · doi:10.1016/j.neuron.2024.12.016 · Cited by 35
Widespread changes in network activity allow non-invasive detection of mesial temporal lobe seizures
Lam, A. D., Zepeda, R., Cole, A. J., & Cash, S. S. (2016) · Brain · doi:10.1093/brain/aww198 · Cited by 35
Adeno‐associated virus‐based Alzheimer's disease mouse models and potential new therapeutic avenues
Ittner, L. M., Klugmann, M., & Ke, Y. D. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14637 · Cited by 36
Sun, J. L., Stokoe, S. A., Roberts, J. P., Sathler, M. F., Nip, K., Shou, J., Ko, K. H., Tsunoda, S., & Kim, S. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.09.005 · Cited by 36
Sathler, M. F., Khatri, L., Roberts, J. P., Schmidt, I. G., Zaytseva, A., Kubrusly, R. C. C., Ziff, E. B., & Kim, S. (2021) · Journal of Cell Science · doi:10.1242/jcs.257972 · Cited by 38
NOX-induced oxidative stress is a primary trigger of major neurodegenerative disorders
Zilberter, Y., Tabuena, D. R., & Zilberter, M. Y. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102539 · Cited by 35
Saydoff, J. A., Olariu, A., Sheng, J. G., Hu, Z., Li, Q., Garcia, R. A. G., Pei, J., Sun, G. Y., & von Borstel, R. W. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130059 · Cited by 36
Metadata
- Authors
- Palop, J. J.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Palop, Jorge J.
- ORCID
- Palop, Jorge J.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2009-04-01
- Volume
- 66
- Issue
- 4
- Pages
- 435
- ISSN
- 0003-9942 (ISSN-L)
- PMC
- PMC2812914
- OpenAlex
- W2098676436
- Cited by
- 684
- References
- 47
- Citations by year
- 2026: 16 · 2025: 31 · 2024: 47 · 2023: 50 · 2022: 38 · 2021: 46 · 2020: 34 · 2019: 47 · 2018: 33 · 2017: 40 · 2016: 47 · 2015: 42 · 2014: 43 · 2013: 41 · 2012: 39
- FWCI
- 28.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Archives of Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (AG023501, P50AG023501)
- National Institute of Neurological Disorders and Stroke (R01NS041787, NS041787)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Keywords
- Alzheimer's disease, epilepsy, cognitive impairment, amyloid-beta, epileptiform activity, presenilin mutations, amyloid precursor protein, APOE ε4, early-onset Alzheimer's disease, transgenic mouse model, antiepileptic drugs
- MeSH terms
- Alzheimer Disease, Amnesia, Animals, Brain, Cognition Disorders, Disease Models, Animal, Electroencephalography, Epilepsy, Genetic Carrier Screening, Hippocampus, Humans, Mice, Transgenic, Nerve Net, Neural Inhibition, Synaptic Transmission, Picrotoxin, Amyloid beta-Peptides, tau Proteins, GABA Antagonists, Dentate Gyrus, Mice, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
